AHPA charters new Psychedelic Plants and Fungi Committee
Elan Sudberg of Alkemist Labs appointed committee chair
March 23, 2022
At the board meeting on March 8, 2022, the AHPA Board of Trustees chartered the AHPA Psychedelic Plants and Fungi Committee. The purpose of this new committee will be to address issues related to the safe use and responsible commerce of lawfully marketed products derived from psychedelic plants and fungi. Elan Sudberg, CEO of Alkemist Labs, was appointed as the committee's first chair.
“With the emergence of legal psychedelics being professionally used to address major mental health issues, and research finding significant benefits in that context, it's crucial that the category be developed with experience and deliberation,” said Sudberg. “Given that AHPA's mission is to promote the responsible and sustainable commerce of herbal products to ensure that consumers have informed access to a wide variety of safe herbal goods, it's entirely appropriate that AHPA's expertise be utilized to help that sector grow responsibly.”
Those interested in joining the Psychedelic Plants and Fungi Committee are asked to contact Michael McGuffin, who will serve as staff liaison to the committee, at email@example.com.
About AHPA Committees
AHPA's committee system enables AHPA members to collaborate on a wide range of projects that are essential to the advancement of the manufacture, distribution, and marketing of herbal and botanical products. Currently, there are 18 AHPA committees representing the wide range of AHPA members and interests. AHPA members are encouraged and welcome to join any and all committees. For more information, please visit the AHPA website.